Novartis Phase III study shows RLX030 improved symptoms and reduced deaths by one-third in patients with acute heart failure

Novartis Phase III study shows RLX030 improved symptoms and reduced deaths by one-third in patients with acute heart failure

Nov 07, 2012
Source URL: https://qa1.novartis.us/us-en/news/media-releases/novartis-phase-iii-study-shows-rlx030-improved-symptoms-and-reduced-deaths-one-third-patients-acute-heart-failure-0

List of links present in page
  1. https://qa1.novartis.us/us-en/us-en/news/media-releases/novartis-phase-iii-study-shows-rlx030-improved-symptoms-and-reduced-deaths-one-third-patients-acute-heart-failure-0